$1 Million EBITDA Orthotics And Prosthetics (“O and P”) Company located in Central Washington
Investment Highlights
Location: Central Washington
Project Name: OPWAMM1F
Status: New
Revenue: $2,100,000
Adjusted EBITDA: $1,000,000
M&A Healthcare Advisors is exclusively representing a Washington State licensed & American Board for Certification ("ABC") accredited, Orthotics and Prosthetics (“O&P”) company with 3 locations in Central Washington. The company provides a variety of services including evaluation, measurement, fabrication, fitting, and lifetime servicing of external O&P devices. They currently have a client census of over 1,100.
53% of their revenue is generated through Medicare while the remaining 47% is comprised of a blend of in-network insurance providers and Medicaid. In 2021, the company generated $1,754,811 in revenue. In 2022, annual revenue increased to approximately $2.1 million with an adjusted EBITDA margin of $973,998 (46%). Approximately 85% of revenue in 2022 was generated from prosthetic devices and services. In 2023, we forecast the company will generate over $2.1 million in revenue with an adjusted EBITDA margin over $1 million (48%).
Our client’s goal is to sell the business & all its assets but is open to maintaining an active role post-acquisition. If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.
53% of their revenue is generated through Medicare while the remaining 47% is comprised of a blend of in-network insurance providers and Medicaid. In 2021, the company generated $1,754,811 in revenue. In 2022, annual revenue increased to approximately $2.1 million with an adjusted EBITDA margin of $973,998 (46%). Approximately 70% of revenue in 2022 was generated from orthotic devices & services. In 2023, we forecast the company will generate over $2.1 million in revenue with an adjusted EBITDA margin over $1 million (48%).
Our client’s goal is to sell the business & all its assets but is open to maintaining an active role post-acquisition. If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.